We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Japan Cracks Down on Misuse of Trial Data; Pfizer Confirms It Faces Probe
Japan Cracks Down on Misuse of Trial Data; Pfizer Confirms It Faces Probe
Japanese officials launched an investigation Jan. 10 into claims that falsified clinical trial data were used in an Alzheimer’s study involving several major drugmakers, marking an expansion of the country’s scrutiny of trial data misuse.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor